Arnon Rosenthal is the founder of Alector. Latest round: Series A. Backed by Polaris Venture Partners, OrbiMed Advisors. Based in South San Francisco, CA.
Arnon Rosenthal is the Co-Founder and CEO of Alector, a clinical-stage biopharmaceutical company focused on developing therapies for neurodegenerative diseases such as Alzheimer's and Parkinson's. He previously led Alector LLC, which secured Series A financing in 2013 to advance research into Alzheimer's treatments.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide